Keynote 55 Pembrolizumab for Heavily Pre-Treated Patients
Jul 31, 2016 ·
4m 16s
![Keynote 55 Pembrolizumab for Heavily Pre-Treated Patients](https://d3wo5wojvuv7l.cloudfront.net/t_square_limited_480/images.spreaker.com/original/ab910102841a66f50783451b3d291a82.jpg)
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
6th video in our series ASCO 2016 Head and Neck Roundtable, featuring Jared Weiss, MD, Joshua Bauml, MD, and Tanguy Seiwert, MD. Dr. Weiss moderates the discussion regarding keynote 55:...
show more
6th video in our series ASCO 2016 Head and Neck Roundtable, featuring Jared Weiss, MD, Joshua Bauml, MD, and Tanguy Seiwert, MD. Dr. Weiss moderates the discussion regarding keynote 55: Pembrolizumab for heavily pre-treated patients.
show less
Information
Author | cancerGRACE |
Website | - |
Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company